No Detail Found!

Frequency and Severity of Acute Toxicity of Pelvic Radiotherapy for Gynecological Cancer.

Author(s)
Asim Hafiz Department of Oncology, Section of Radiation Oncology, The Aga Khan University Hospital, Karachi, Pakistan
Ahmed Nadeem Abbasi Department of Oncology, Section of Radiation Oncology, The Aga Khan University Hospital, Karachi, Pakistan
Nasir Ali Department of Oncology, Section of Radiation Oncology, The Aga Khan University Hospital, Karachi, Pakistan
Khurshid Ahmed Khan Department of Oncology, Section of Radiation Oncology, The Aga Khan University Hospital, Karachi, Pakistan
Bilal Mazhar Qureshi Department of Oncology, Section of Radiation Oncology, The Aga Khan University Hospital, Karachi, Pakistan
Abstract
Objective: To determine the frequency and severity of acute toxicity of pelvic radiotherapy for gynecological cancer. Study Design: A case series. Place and Duration of Study: Department of Oncology, The Aga Khan University Hospital, Karachi, from March 2011 to June 2012. Methodology: A total of 99 patients with histologically proven uterine and cervical cancer, receiving radiation therapy, were enrolled into the study after informed consent on justification of inclusion and exclusion criteria. Patients were evaluated for the frequency and severity of pelvic radiotherapy's side effects according to toxicity criteria based on RTOG/EORTC and CTC version 2 criteria at the start, during and at the end of treatment. The data was analyzed by using SPSS version 16. Results: Out of the 99 enrolled patients, 58 (58.6%) had uterine and 41 (41.4%) had cervical cancer. Mean age was 54.54 ±10.29 years. Thirty-five (35.4%) patients received chemotherapy with RT. Mean RT dose was 60.72 ±7.15 Gy. The most common gastrointestinal adverse effect was diarrhea in 64 (64.6%) followed by proctitis in 55 (55.5%), nausea in 33 (33.3%) and vomiting in 16 (16.2%) patients. Grade (G) 1 was the most frequently observed severity. The most common hematological toxicity was anemia in 37.8% (n=31/82) {(G1=18 (21.9%), G2=11 (13.4%), G3=2 (2.4%)} followed by thrombocytopenia in 22.8% (21/92) {(G1=16 (17.3%), G2=2 (2.1%), G3=3 (3.2%)} and neutropenia in 21 (21.2%) {(G1=12 (12.1%), G2=5 (5%), G3=3 (3%), G4=1 (1%)}. Urinary toxicity was observed in 49 (49.5%) patients. On stratification, chemotherapy and higher RT dose were strong predictor of increased hematological and upper gastrointestinal toxicity (p 60 years for diarrhea (p < 0.05). Conclusion: The frequency and severity of acute toxicity of pelvic radiotherapy in women with gynecologic cancers was found intermediate to high.
Publication Details
Page(s) 802-806
DOI DOI not available
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 25, Issue: 11, Year: 2015

Request the full text from PASTIC

References
JemalA,BrayF,CenterMM,FerlayJ,WardE,FormanD, 2011.,CA Cancer J Clin 61 69 -90
HanifM,ZaidiP,KamalS,HameedA, 2009.Institution-based cancer incidence in a local population in Pakistan: nine year data analysis,Asian Pac J Cancer Prev 10 227 -30
BhurgriY,BhurgriA,NishterS,AhmedA,UsmanA,PervezS, 2006.Pakistan-country profile of cancer and cancer control 1995-2004,J Pak Med Assoc 56 124 -30
BlakeP,SwartAM,OrtonJ,KitchenerH,WhelanT,LukkaH, 2009.Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomized trials): pooled trail result, systematic review, and meta-analysis,Lancet 373 137 -46
HogbergT.,Oncol (R Coll Radiol, 2008.Adjuvant chemotherapy in endometrial carcinoma: overview of randomized trials, 20 463 -9
RosePG,AliS,WatkinE,ThippenJT,DeppeG,DanielL, 2007.Long-term follow-up of a randomized trial comparing concurrent single agent cisplatin, cisplatin- based combination chemotherapy, or hydroxyurea during pelvic irradiation for locally advanced cervical cancer: a gynecologic oncology group study,J Clin Oncol 25 2804 -10
ParveenS,AkhtarN,ShahidMA, 1995.Radiotherapy of cervical cancer: experience with combined brachytherapy and external beam therapy,Pak J Med Res 34 95 -8
LandoniF,ManeoA,ColomboA,PlacaF,MilaniR,PeregoP, 1997.Randomized study of radical surgery vs. radiotherapy for stage Ib-IIa cervical cancer,Lancet 350 535 -40
PetersWA,LiuPY,BarrettRJ,StockRJ,MonkBJ,BerekJS, 2000.Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high risk early-stage cancer of the cervix,J Clin Oncol 18 1606 -13
HuscherA,BiguardiM,MagriE,VitaliE,PasinettiN,CostaL, 2009.Determinants of small bowel toxicity in postoperative pelvic irradiation for gynecological malignancies,Anticancer Res 29 4821 -6
VazAF,Pinto-NetoAM,CondeDM,Costa-PaivaL,MoraisSS,EstevesSB, 2008.Quality of life and acute toxicity of radiotherapy in women with gynecologic cancer: a prospective longitudinal study,Arch Gynecol Obstet 278 215 -23
TanLT,RussellS,Oncol (R Coll Radiol, 2004.Acute toxicity of chemoradiotherapy for cervical cancer: the Addenbrooke's experience, 16 255 -60
OhnoT,KatoS,WakatsukiM,NodaSE,MurakamiC,NakamuraM, 2006.Incidence and temporal pattern of anorexia, diarrhea, weight loss, and leucopenia in patients with cervical cancer treated with concurrent radiation therapy and weekly cisplatin: comparison with radiation therapy alone,Gynecol Oncol 103 94 -9
KirwanJM,SymondsP,GreenJA,TierneyJ,CollingwoodM,WilliamsCJ, 2003.A systematic review of acute and late toxicity of concomitant chemoradiation for cervical cancer,Radiother Oncol 68 217 -26
Jereczek-FossaBA,BadzioA,JassemJ, 2003.Factors determining acute normal tissue reaction during postoperative radiotherapy in endometrial cancer: analysis of 317 consecutive cases,Radiother Oncol 68 33 -9
CoxJD,StetzJ,PajakTF, 1995.Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Cancer Research and Treatment of Cancer (EORTC),Int J Radiat Oncol Biol Phys 31 1341 -6
Cancer, 1998.[database on the Internet],[cited 1999 Apr 30 4 -30
KeysHM,RobertsJA,BrunettoVL,ZainoRJ,SpirtosNM,BlossJD, 2004.A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a gynecologic oncology group study,Gynecol Oncol 92 744 -51
RobertsKB,UrdanetaN,VeraR,VeraA,GutierrezE,AguilarY, 2000.Interim results of a randomized trial of mitomycin C as an adjunct to radical radiotherapy in the treatment of locally advanced squamous cell carcinoma of the cervix,Int J Cancer 90 206 -23
0

Citations

0

Downloads

114

Views